Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Copart, Inc. (CPRT): The Best Stock in the Vehicle Remarketing Industry

With the current trading price of $31.67 per share, Copart is worth $3.95 billion in the stock market. The market is valuing Copart at 17.4x forward earnings and 12.34x EV/EBITDA. Copart’s valuation surprisingly is still cheaper than CarMax’s. CarMax is valued at 18.3x forward P/E and more than 17x EV/EBITDA. AutoZone seems to be the cheapest, with 11.12x forward earnings and 8.72x EV/EBITDA.

Looking Forward

Since 2012, Copart has expanded its business overseas. In August, it acquired Ride Safely Middle East Auction in Dubai, UAE. In September, it announced the opening of its new facility in New Hampshire to address growing demand volume in the New England region. In November, the business was expanded to Germany via the acquisition of WOM Wreck Online Marketing Aktiengesellschaft.  EPS is estimated to grow to $1.82 next year. Personally, I think in a few years time, Copart would keep expanding its business overseas using its sustainable cash flow from operations. Thus, its EPS would be on the rise.

Foolish Bottom Line

Although the CEO is selling out at its 52-week high, he and his related family members are still holding significant stakes in Copart. The superior margin and return seem to be quite attractive. However, the double digit EV multiples have resisted me from initiating a long position in Copart at the moment.

The article The Best Stock in the Vehicle Remarketing Industry originally appeared on Fool.com and is written by Anh HOANG.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!